Reply: Computerised tomography features of giant cell tumour of the knee are associated with local recurrence after extended curettage
暂无分享，去创建一个
[1] Zhenglian Zhang. Letter to the editor regarding the article by Zhou et al.: Computerised tomography features of giant cell tumour of the knee are associated with local recurrence after extended curettage , 2022, International Orthopaedics.
[2] Changqing Zhang,et al. Computerised tomography features of giant cell tumour of the knee are associated with local recurrence after extended curettage , 2021, International Orthopaedics.
[3] J. Blay,et al. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study. , 2019, The Lancet. Oncology.
[4] D. Campanacci,et al. Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence? , 2018, Clinical orthopaedics and related research.
[5] C. Errani,et al. Denosumab May Increase the Risk of Local Recurrence in Patients with Giant-Cell Tumor of Bone Treated with Curettage , 2018, The Journal of bone and joint surgery. American volume.
[6] David M. Thomas,et al. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study. , 2013, The Lancet. Oncology.
[7] David M. Thomas,et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. , 2010, The Lancet. Oncology.